Medical Regulation > Nova Content

  On August 25, 2011 Johnson & Johnson Pharmaceutical Research and Development, L.L.C (J&JPRD) received approval from the US Food and Drug... Read More »

CHICAGO (Reuters) - Stimulants used to treat attention deficit hyperactivity disorder do not increase the risk of heart attacks, strokes or sudden death, U.S... Read More »

  By Andrew M. Seaman               NEW YORK (Reuters Health) - An international survey of cancer doctors shows... Read More »

  GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and private sector to... Read More »

(Reuters) - U.S. device reviewers said a Medtronic Inc device was effective for treating a common heart rhythm disorder, but raised concerns about its safety... Read More »

  By Jim Finkle               BOSTON (Reuters) - Medtronic Inc has asked software security experts to investigate... Read More »

  (Reuters) - Smokers who take Pfizer's pill Chantix to help them quit do not have a higher risk of being hospitalized for psychiatric events such as... Read More »

  (Reuters) - Exelixis Inc's drug to treat a rare form of thyroid cancer met the main goal of a late-stage study, prompting the company to look to an... Read More »